Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28;384(4):378-381.
doi: 10.1056/NEJMcibr2032177.

Antigen Presentation by B Cells in Multiple Sclerosis

Scott S Zamvil  1 , Stephen L Hauser  1
Affiliations

Antigen Presentation by B Cells in Multiple Sclerosis

Scott S Zamvil et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure I.
Figure I.
Model illustrating how human leukocyte antigen (HLA)-DR15-associated self peptides (SPs) on B cells influence the autoreactive T cell repertoire in multiple sclerosis (MS). Panel A shows the MS-associated HLA-DR15 locus. HLA-D proteins, which include three isotypes (-DQ, -DP and -DR), are major histocompatibility complex (MHC) class II molecules composed of alpha chain and beta chain heterodimers. MHC class II molecules, which are expressed antigen-presenting cells (e.g. B cells, monocytes and central nervous system [CNS] microglia), are required for the presentation of processed peptide fragments of foreign antigens or autoantigens to CD4+ T cells. The DR15 haplotype contains one alpha chain gene, DRA*01:01P, and two beta chain genes, DRB5*01:01 and DRB1*15:01 (Panel A). Pairing of the alpha chain with the beta chain encoded by DRB5*01:01 or the beta chain encoded by DRB1*15:01, respectively creates DR2a and DR2b heterodimers. A recent study by Wang et al. showed that small peptide fragments derived from DR2a and DR2b proteins themselves bind intact DR2a and DR2b molecules on B cells and serve as antigens for presentation to T cells (Panel B). Small peptides derived from the beta chains DRB5 (red) and DRB1 (green), bind to DR2a and small peptides from the alpha chain, DRA (blue), bound to DR2b. Panel C shows that HLA small peptides, which represent a large proportion of peptides binding DR2a and DR2b molecules on peripheral memory B cells in patients with multiple sclerosis, exhibit low avidity T cell receptor (TCR) engagement, supporting homeostatic (non-pathogenic) maintenance of HLA DR small peptide–specific memory T cells. Panel D shows how pathogenic small peptides, for example, peptides derived from RASGRP2, which is expressed by both B cells and neurons in the cortical gray matter, may replace DR2a and DR2b small peptides, leading to high avidity TCR engagement that would then promote the activation of pathogenic-peptide CD4+ T cells, which then traffic to the CNS. Antigen-presenting cells in the CNS that express DR2a and DR2b may present the corresponding pathogenic peptide expressed in the CNS (for example, RASGRP2) to CD4+ T cells, eliciting inflammatory responses and tissue damage.
See this image and copyright information in PMC

References

    1. Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. The New England journal of medicine 2018;378:169–80. - PMC - PubMed
    1. Hauser SL, Bar-Or A, Comi G, et al. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med 2017;376:221–34. - PubMed
    1. Hauser SL, Bar-Or A, Cohen JA, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med 2020;383:546–57. - PubMed
    1. Brandle SM, Obermeier B, Senel M, et al. Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins. Proceedings of the National Academy of Sciences of the United States of America 2016;113:7864–9. - PMC - PubMed
    1. International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 2019;365(6460):eaav7188. - PMC - PubMed

MeSH terms